國家衛生研究院 NHRI:Item 3990099045/6948
English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 12145/12927 (94%)
造访人次 : 916429      在线人数 : 1434
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧：
  • 您可在西文检索词汇前后加上"双引号"，以获取较精准的检索结果
  • 若欲以作者姓名搜寻，建议至进阶搜寻限定作者字段，可获得较完整数据
    •  进阶搜寻
    主页 ‧ 登入 ‧ 上传 ‧ 说明 ‧ 关于NHRI ‧ 管理 到手机版


    jsp.display-item.identifier=請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/6948


    题名: Significance of 14-3-3beta expression in hepatocellular carcinoma and its correlation with extrahepatic metastasis and patient's survival
    其它题名: Significance of 14-3-3β expression in hepatocellular carcinoma and its correlation with extrahepatic metastasis and patient's survival
    作者: Liu, TA;Jan, YJ;Hung, YL;Liang, SM;Ko, BS;Liou, JY
    贡献者: Institute of Cellular and Systems Medicine
    摘要: 14-3-3 proteins have been reported to interact with numerous intracellular signaling molecules in regulation of various cellular functions. 14-3-3β has been shown to be associated with integrinβ1 to enhance cell adhesion and migration. However, its role on tumor progression and cancer metastasis has not been well investigated. Here, we report that overexpression of 14-3-3β significantly promotes hepatocellular carcinoma (HCC) cell growth and increase cancer cell anchorage-independent growth. Furthermore, an enhanced migratory capacity of both 14-3-3β- and integrinβ1-overexpressing cells was observed suggesting their importance in regulating cell adhesion and migration. In clinical trials, we analyzed the correlation of 14-3-3β in primary and subsequent metastatic tissues of HCC patients with its relevance in clinic-pathological parameters. 14-3-3β is overexpressed in primary tumors and predicts a higher 5-year incidence of subsequent metastasis. Additionally, expression of 14-3-3β is significantly correlated with a worse 5-year overall survival. Taken together, these findings reveal that 14-3-3β overexpression promotes tumor progression, and is associated with subsequent extrahepatic metastasis and worse survival. 14-3-3β might serve as a potentially prognostic biomarker and therapeutic target for HCC
    日期: 2011-04
    關聯: FASEB Journal. 2011 Apr;25:698.9.
    Link to: http://www.fasebj.org/cgi/content/meeting_abstract/25/1_MeetingAbstracts/698.9
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0892-6638&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000310708404439
    显示于类别:[劉俊揚] 會議論文/會議摘要

    文件中的档案:

    没有与此文件相关的档案.



    在NHRI中所有的数据项都受到原著作权保护.

    TAIR相关文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈